WO2004047612A3 - Procédés de thérapie et de diagnostic - Google Patents

Procédés de thérapie et de diagnostic Download PDF

Info

Publication number
WO2004047612A3
WO2004047612A3 PCT/US2003/036971 US0336971W WO2004047612A3 WO 2004047612 A3 WO2004047612 A3 WO 2004047612A3 US 0336971 W US0336971 W US 0336971W WO 2004047612 A3 WO2004047612 A3 WO 2004047612A3
Authority
WO
WIPO (PCT)
Prior art keywords
tlr10
therapy
diagnosis
methods
polypeptides
Prior art date
Application number
PCT/US2003/036971
Other languages
English (en)
Other versions
WO2004047612A2 (fr
Inventor
Douglas Dedera
Peter C R Emtage
Original Assignee
Nuvelo Inc
Douglas Dedera
Peter C R Emtage
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/302,444 external-priority patent/US20040022786A1/en
Priority claimed from US10/327,491 external-priority patent/US20040023870A1/en
Application filed by Nuvelo Inc, Douglas Dedera, Peter C R Emtage filed Critical Nuvelo Inc
Priority to EP03786850A priority Critical patent/EP1567863A4/fr
Priority to CA002506356A priority patent/CA2506356A1/fr
Priority to AU2003295649A priority patent/AU2003295649A1/en
Publication of WO2004047612A2 publication Critical patent/WO2004047612A2/fr
Publication of WO2004047612A3 publication Critical patent/WO2004047612A3/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

L'invention concerne une thérapie de ciblage utilisant des polypeptides TLR10, des acides nucléiques codant pour des polypeptides TLR10, des anticorps anti-TLR10, qui fournit un procédé qui élimine ou qui inhibe la croissance de cellules cancéreuses exprimant la protéine TLR10. L'invention concerne des procédés de thérapie et de diagnostic de troubles liés aux cellules exprimant la protéine TLR10.
PCT/US2003/036971 2002-11-22 2003-11-19 Procédés de thérapie et de diagnostic WO2004047612A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP03786850A EP1567863A4 (fr) 2002-11-22 2003-11-19 Procedes de therapie et de diagnostic
CA002506356A CA2506356A1 (fr) 2002-11-22 2003-11-19 Procedes de therapie et de diagnostic
AU2003295649A AU2003295649A1 (en) 2002-11-22 2003-11-19 Methods of therapy and diagnosis

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US10/302,444 2002-11-22
US10/302,444 US20040022786A1 (en) 2000-01-21 2002-11-22 Methods of therapy and diagnosis using targeting of cells that express toll-like receptor proteins
US10/327,491 2002-12-19
US10/327,491 US20040023870A1 (en) 2000-01-21 2002-12-19 Methods of therapy and diagnosis using targeting of cells that express toll-like receptor proteins
US64122203A 2003-08-13 2003-08-13
US10/641,222 2003-08-13

Publications (2)

Publication Number Publication Date
WO2004047612A2 WO2004047612A2 (fr) 2004-06-10
WO2004047612A3 true WO2004047612A3 (fr) 2005-04-14

Family

ID=32397926

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/036971 WO2004047612A2 (fr) 2002-11-22 2003-11-19 Procédés de thérapie et de diagnostic

Country Status (4)

Country Link
EP (1) EP1567863A4 (fr)
AU (1) AU2003295649A1 (fr)
CA (1) CA2506356A1 (fr)
WO (1) WO2004047612A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1765399A1 (fr) 2004-07-09 2007-03-28 Schering Aktiengesellschaft Polytherapie a base d'anticorps anti-cd20 radiomarques, destinee au traitement du lymphome b
AU2005269733B2 (en) * 2004-07-20 2008-10-30 Schering Corporation Induction of apoptosis in Toll-like receptor expressing tumor cells

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL135345A0 (en) * 1997-10-17 2001-05-20 Genentech Inc Human toll homologues

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] 2 August 1999 (1999-08-02), GODDARD ET AL.: "Human toll protein PRO358", XP002999283, Database accession no. AAY05868 *
DATABASE GENBANK [online] 27 March 2001 (2001-03-27), CHUANG ET AL.: "Homo sapiens too-like receptor 10 mRNA, complete cds", XP002999281, accession no. EMBL Database accession no. AF296673 *
DATABASE GENBANK [online] 5 April 2000 (2000-04-05), BAKER ET AL.: "Membrane-bound protein PRO358", XP002999284, Database accession no. AAY66644 *
DATABASE GENESEQ [online] 26 March 2002 (2002-03-26), HARDIMAN ET AL.: "Human DNAS toll like receptor (DTLR) 8 cDNA #3", XP002999282, Database accession no. AAD26299 *
See also references of EP1567863A4 *

Also Published As

Publication number Publication date
AU2003295649A1 (en) 2004-06-18
CA2506356A1 (fr) 2004-06-10
WO2004047612A2 (fr) 2004-06-10
EP1567863A4 (fr) 2007-10-03
EP1567863A2 (fr) 2005-08-31

Similar Documents

Publication Publication Date Title
EP1137658A4 (fr) TECHNIQUES DE MODULATION DE L'EXPRESSION DE MOLECULES D'ADHESION CELLULAIRE INDUITE PAR LE FACTEUR DE NECROSE DES TUMEURS-$g(a)
WO2002099055A3 (fr) Cip comme modificateurs de la voie p53 et methodes d'utilisation associees
WO2005056606A3 (fr) Proteines optimisees qui ciblent le recepteur du facteur de croissance epidermique
WO2004046342A3 (fr) Nouvelles cibles geniques et ligands se liant a ces cibles dans le traitement et le diagnostic de carcinomes
WO2003012057A3 (fr) Modulation antisens de l'expression du serum amyloide a4
UA93855C2 (ru) Вакцина, способствует росту, базирующейся ha нейтрализующем эпитопе
WO2003010284A3 (fr) Modulation antisens de l'expression de la proteine reactive c
WO2004098377A3 (fr) Procedes et compositions pour le diagnostic et la therapie de troubles lies a la parkine
WO2003022222A3 (fr) Modulation anti-sens de l'expression d'une proteine kinase r
WO2002092013A3 (fr) Methodes de traitement des maladies du foie et des lesions du foie a l'aide de l'hormone de croissance et de la proteine foxm1b
WO2002077176A3 (fr) Proteines presentant une expression aberrante dans des tumeurs microdissequees capturees au laser
WO2004037198A3 (fr) Induction de la mort de cellules tumorales provoquee par un anticorps
WO2004051269A3 (fr) Proteine de replication
WO2005079490A3 (fr) Procedes de therapie et de diagnostic reposant sur le ciblage de cellules qui expriment les polypeptides steap2
WO2004047758A3 (fr) Methodes therapeutiques et diagnostiques mettant en application le ciblage de cellules exprimant p2y10
WO2004069860A3 (fr) Proteines conjuguees a isg15
WO2004047612A3 (fr) Procédés de thérapie et de diagnostic
WO2004053061A8 (fr) Procedes d'immunotherapie et de diagnostic par ciblage de cellules exprimant des proteines lax
WO2005060375A3 (fr) Procedes de therapie et de diagnostic reposant sur le ciblage de cellules qui expriment une proteine du type recepteur de type immoglobuline de cellule tueuse.
WO2001049832A3 (fr) Transduction de recombinases pour ciblage genetique inductible
WO2001088137A3 (fr) Proteines du type proteine adaptatrice myd88
WO2004049917A3 (fr) Procedes de therapie et de diagnostic utilisant le ciblage de cellules d'expression de ly-9
AU2003237493A1 (en) Methods for treating diseases or conditions with peptide constructs
WO2004078918A3 (fr) Materiel et methodes de traitement et de diagnostic utilisant le ciblage de cellules exprimant les polypeptides dcal-hy
WO2003032899A3 (fr) Procedes et materiaux permettant de cibler et d'affecter des cellules selectionnees

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003295649

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2506356

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2003786850

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2003786850

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP